Acrivon Therapeutics, Inc. Common Stock ( ACRV) - Key Metrics
ACRV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.43 | -$0.36 | -$0.36 |
| 2026Q1 | $0 | -$0.49 | -$0.53 | -$0.53 |
| 2025Q4 | $0 | -$0.49 | -$0.40 | -$0.40 |
| 2025Q3 | $0 | -$0.47 | -$0.32 | -$0.34 |
| 2025Q2 | $0 | -$0.55 | -$0.43 | -$0.44 |
ACRV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.03 |
| 2026Q1 | 0% | -0.71 |
| 2025Q4 | 0% | -1.23 |
| 2025Q3 | 0% | -0.96 |
| 2025Q2 | 0% | -0.54 |
ACRV
Price: $2.21
52 week price:
Earnings Per Share: -1.88 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 87.7 million